Qing‐Hai Ye

10.8k total citations · 3 hit papers
126 papers, 8.2k citations indexed

About

Qing‐Hai Ye is a scholar working on Hepatology, Molecular Biology and Oncology. According to data from OpenAlex, Qing‐Hai Ye has authored 126 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Hepatology, 47 papers in Molecular Biology and 45 papers in Oncology. Recurrent topics in Qing‐Hai Ye's work include Hepatocellular Carcinoma Treatment and Prognosis (44 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers) and MicroRNA in disease regulation (15 papers). Qing‐Hai Ye is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (44 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (23 papers) and MicroRNA in disease regulation (15 papers). Qing‐Hai Ye collaborates with scholars based in China, United States and Taiwan. Qing‐Hai Ye's co-authors include Lun–Xiu Qin, Hu‐Liang Jia, Xin Wei Wang, Anuradha Budhu, Marshonna Forgues, Zhao–You Tang, Qiongzhu Dong, Ning Ren, Junfang Ji and Taro Yamashita and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Qing‐Hai Ye

124 papers receiving 8.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features

2008 958 citations Taro Yamashita, Anuradha Budhu et al. Gastroenterology profile →
EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma

2008 577 citations Taro Yamashita, Marshonna Forgues et al. Cancer Research profile →
Identification of metastasis-related microRNAs in hepatocellular carcinoma

2008 574 citations Anuradha Budhu, Hu‐Liang Jia et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Qing‐Hai Ye	4.1k	3.3k	2.6k	2.2k	1.1k	126	8.2k
Marshonna Forgues	5.5k 1.3×	3.9k 1.2×	2.5k 1.0×	2.0k 0.9×	816 0.7×	51	9.4k
Hu‐Liang Jia	4.6k 1.1×	3.6k 1.1×	2.0k 0.8×	1.3k 0.6×	738 0.7×	92	7.5k
Gabrielle Couchy	3.0k 0.7×	2.1k 0.6×	1.4k 0.5×	2.0k 0.9×	1.0k 0.9×	64	6.1k
Daniela Sia	2.2k 0.5×	1.8k 0.5×	1.7k 0.6×	1.9k 0.8×	935 0.8×	50	5.5k
Zhao–You Tang	2.4k 0.6×	1.8k 0.5×	1.5k 0.6×	2.0k 0.9×	923 0.8×	164	5.7k
Ronnie T.P. Poon	3.1k 0.7×	1.8k 0.5×	2.0k 0.7×	4.0k 1.8×	1.5k 1.3×	106	8.4k
Qiongzhu Dong	4.5k 1.1×	3.6k 1.1×	1.8k 0.7×	701 0.3×	551 0.5×	131	7.4k
Sandra Rebouissou	2.5k 0.6×	1.6k 0.5×	1.0k 0.4×	1.8k 0.8×	1.2k 1.0×	40	5.0k
Zhao‐Chong Zeng	2.2k 0.5×	1.4k 0.4×	1.5k 0.6×	1.4k 0.6×	1.1k 1.0×	198	5.1k
Éric Letouzé	2.6k 0.6×	2.1k 0.6×	895 0.3×	1.1k 0.5×	1.1k 1.0×	59	5.3k

Countries citing papers authored by Qing‐Hai Ye

Since Specialization

Citations

This map shows the geographic impact of Qing‐Hai Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qing‐Hai Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qing‐Hai Ye more than expected).

Fields of papers citing papers by Qing‐Hai Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qing‐Hai Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qing‐Hai Ye. The network helps show where Qing‐Hai Ye may publish in the future.

Co-authorship network of co-authors of Qing‐Hai Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Qing‐Hai Ye. A scholar is included among the top collaborators of Qing‐Hai Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qing‐Hai Ye. Qing‐Hai Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Mincheng, Peiyi Xie, Wenxin Xu, et al.. (2025). Liver regeneration–associated hepatocellular YAP1 activation prevents colorectal cancer liver metastasis through glutamine competition. Science Advances. 11(34). eadw6926–eadw6926.

Weng, Jialei, Mincheng Yu, Qiang Yu, et al.. (2025). Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma. Gut. 75(3). 620–634. 1 indexed citations

Xie, Peiyi, Mincheng Yu, Mengyuan Wu, et al.. (2024). ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis. Cancer Research. 85(2). 299–313. 11 indexed citations

Chen, Zheng, Mincheng Yu, Bo Zhang, et al.. (2024). SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion. OncoImmunology. 13(1). 2376264–2376264. 3 indexed citations

Chang, Wenju, Qing‐Hai Ye, Yu Liu, et al.. (2023). Robotic versus open surgery for simultaneous resection of rectal cancer and liver metastases: a randomized controlled trial. International Journal of Surgery. 109(11). 3346–3353. 19 indexed citations

Chang, Wenju, Yijiao Chen, Li Ren, et al.. (2023). Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/NRAS/BRAF mutations or right-sided colon cancer: a retrospective cohort study. International Journal of Surgery. 109(10). 3070–3077. 2 indexed citations

Zhou, Chenhao, Jialei Weng, Shaoqing Liu, et al.. (2023). Whole-exome sequencing reveals the metastatic potential of hepatocellular carcinoma from the perspective of tumor and circulating tumor DNA. Hepatology International. 17(6). 1461–1476. 3 indexed citations

Lv, Yang, Qingyang Feng, Ye Wei, et al.. (2020). Benefits of multi‐disciplinary treatment strategy on survival of patients with colorectal cancer liver metastasis. SHILAP Revista de lepidopterología. 10(3). e121–e121. 12 indexed citations

Li, Hui, Chia‐Wei Li, Xiaoqiang Li, et al.. (2019). MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. Gastroenterology. 156(6). 1849–1861.e13. 154 indexed citations

10.

Takai, Atsushi, Hien Dang, Naoki Oishi, et al.. (2019). Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM+ Hepatocellular Carcinoma. Cancer Research. 79(9). 2379–2391. 23 indexed citations

11.

Ye, Qing‐Hai, Wenwei Zhu, Jubo Zhang, et al.. (2016). GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis. Cancer Cell. 30(3). 444–458. 178 indexed citations

12.

Zhu, Wenwei, Lei Guo, Hu‐Liang Jia, et al.. (2013). Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma. Clinical Cancer Research. 19(14). 3944–3954. 111 indexed citations

13.

Ye, Lechi, Tianshu Liu, Li Ren, et al.. (2013). Randomized Controlled Trial of Cetuximab Plus Chemotherapy for Patients With KRAS Wild-Type Unresectable Colorectal Liver-Limited Metastases. Journal of Clinical Oncology. 31(16). 1931–1938. 296 indexed citations

14.

Ren, Ning, Jincai Wu, Qiongzhu Dong, et al.. (2011). Association of Specific Genotypes in Metastatic Suppressor HTPAP with Tumor Metastasis and Clinical Prognosis in Hepatocellular Carcinoma. Cancer Research. 71(9). 3278–3286. 17 indexed citations

15.

Dai, Chun, Qiongzhu Dong, Ning Ren, et al.. (2011). Downregulation of HTPAP transcript variant 1 correlates with tumor metastasis and poor survival in patients with hepatocellular carcinoma. Cancer Science. 102(3). 583–590. 3 indexed citations

16.

Huang, Hua, et al.. (2010). Expression and prognostic significance of osteopontin and caspase‐3 in hepatocellular carcinoma patients after curative resection. Cancer Science. 101(5). 1314–1319. 51 indexed citations

17.

Li, Guocai, Qing‐Hai Ye, Yuhua Xue, et al.. (2010). Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97‐H cell line. Cancer Science. 101(12). 2546–2553. 83 indexed citations

18.

Yamashita, Taro, Marshonna Forgues, Wei Wang, et al.. (2008). EpCAM and α-Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma. Cancer Research. 68(5). 1451–1461. 577 indexed citations breakdown →

19.

Jia, Hu‐Liang, et al.. (2008). [Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma].. PubMed. 30(4). 440–3. 4 indexed citations

20.

Jia, Hu‐Liang, Qing‐Hai Ye, Lun–Xiu Qin, et al.. (2007). Gene Expression Profiling Reveals Potential Biomarkers of Human Hepatocellular Carcinoma. Clinical Cancer Research. 13(4). 1133–1139. 169 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact